<DOC>
	<DOCNO>NCT00795314</DOCNO>
	<brief_summary>Uterine curettage usually perform anesthesia propofol-fentanyl para-cervical block , generally significant incidence respiratory depression increase demand intraoperative monitoring , unavoidable insufficient blockade result intraoperative suffer pain . Butorphanol analgesic combine effect mu kappa opioid receptor lead role analgesia sedation . The investigator hypothesize combined propofol butorphanol uterine curettage would produce optimal effectiveness two drug add sedative analgesic effect together . In addition , would decrease intraoperative consumption propofol without increase incidence side effect . Furthermore , combination would alleviate postoperative pain .</brief_summary>
	<brief_title>Propofol-butorphanol Anesthesia During Uterine Curettage</brief_title>
	<detailed_description />
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Fentanyl</mesh_term>
	<mesh_term>Butorphanol</mesh_term>
	<criteria>ASA status III ; Performing abortion operation ( medical druginduced ) ; Requiring painless abortion ; &lt; 19yrs , &gt; = 45yrs ; History central active drug administration ; Drug abuse ; Hypertension ; Diabetes ; Any chronic disease ; Allergy study drug ; Habit overvolume alcohol drinking ; Records history centrally active drug use psychiatry ; Any organic disorder .</criteria>
	<gender>Female</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Opioids</keyword>
	<keyword>General anesthesia</keyword>
</DOC>